IMPL Market Cap History



Below is a table of the IMPL market cap history going back to 6/4/2021:

Date IMPL Market Cap
6/4/2021218.98M
8/11/2021362.49M
11/10/2021265.64M
3/16/2022153.47M
5/10/2022142.99M
8/10/2022198.46M
11/8/202294.25M
3/15/202322.80M
5/8/202365.43M
8/14/202327.31M
11/8/20235.52M

Also see: IMPL Shares Outstanding History
and IMPL YTD Return
IMPL Historical Market Cap:
-78.01% CAGR
IMPL Historical Market Cap: +-78.01% CAGR

Mouse over chart for data details
6/4/20218/11/202111/10/20213/16/20225/10/20228/10/202211/8/20223/15/20235/8/20238/14/202311/8/2023
Impel Pharmaceuticals is a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with unmet medical needs, with an initial focus on the Central Nervous System. Co. has launched Trudhesa for the acute treatment of migraine headaches with or without aura in adult patients. Co. is developing several product candidates, including INP105 for the acute treatment of agitation and aggression in patients with Autism Spectrum Disorder. Co.'s pipeline of proprietary product candidates also includes INP107 for the treatment of OFF episodes in Parkinson's Disease. We show 11 historical shares outstanding datapoints in our IMPL shares outstanding history coverage, used to compute IMPL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IMPL market cap history over the course of time is important for investors interested in comparing IMPL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IMPL versus a peer is one thing; comparing IMPL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IMPL can fluctuate over the course of history. With this page we aim to empower investors researching IMPL by allowing them to research the IMPL market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree IMPL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Impel NeuroPharma (IMPL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

IMRA Market Cap History
IMRX Market Cap History
IMUX Market Cap History
IMV Market Cap History
IMVT Market Cap History
INAB Market Cap History
INBS Market Cap History
INBX Market Cap History
INCY Market Cap History
INDP Market Cap History
More Healthcare companies »

 

IMPL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.